<p>WINTON GROUP Ltd 在最近向美國證券交易委員會提交的 13F 文件中披露，在第四季度購買了 Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 免費報告）的新股份。該公司購買了 146,030 股，價值約為 2,098,000 美元。WINTON GROUP Ltd 在最近的報告期末持有 Oscar Health 約 0.06% 的股份。</p>
<ul>
<li>5 只小盤股具有爆炸性上漲潛力</li>
</ul>
<p>其他幾家機構投資者和對沖基金也買賣了 OSCR 的股份。Jones Financial Companies Lllp 在第一季度將其在 Oscar Health 的持倉增加了 7,473.3%。Jones Financial Companies Lllp 現在擁有 2,272 股該公司的股票，價值 30,000 美元，此前在上個季度額外購買了 2,242 股。Strs Ohio 在第一季度購買了價值約 30,000 美元的 Oscar Health 新股份。Fifth Third Bancorp 在第四季度將其在 Oscar Health 的持倉增加了 148.7%。Fifth Third Bancorp 現在擁有 2,363 股該公司的股票，價值 34,000 美元，此前在上個季度額外購買了 1,413 股。Quarry LP 在第三季度將其在 Oscar Health 的持倉增加了 439.8%。Quarry LP 現在擁有 1,803 股該公司的股票，價值 34,000 美元，此前在上個季度額外購買了 1,469 股。最後，Binnacle Investments Inc 在第二季度購買了價值約 75,000 美元的 Oscar Health 新股份。目前，75.70% 的股票由機構投資者持有。</p>
<h2>分析師評級上調與下調</h2>
<p>一些股票研究分析師最近對該公司發表了看法。富國銀行設定了 Oscar Health 的目標價為 20.00 美元，並在週四的研究報告中給予該股票 “持平” 評級。Robert W. Baird 將 Oscar Health 的目標價從 15.00 美元上調至 19.00 美元，並在週四的研究報告中給予該股票 “中性” 評級。Jefferies Financial Group 將 Oscar Health 的評級從 “表現不佳” 上調至 “持有”，並在 4 月 20 日的研究報告中將該股票的目標價從 10.00 美元上調至 16.00 美元。瑞銀集團將 Oscar Health 的目標價從 15.00 美元上調至 20.00 美元，並在週四的研究報告中給予該股票 “中性” 評級。最後，巴克萊將 Oscar Health 的目標價從 21.00 美元上調至 30.00 美元，並在週二的研究報告中給予該股票 “持平” 評級。一位研究分析師給予該股票 “強烈買入” 評級，兩位給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該公司的平均評級為 “持有”，平均目標價為 20.22 美元。</p>
<p><strong>獲取我們關於 OSCR 的最新報告</strong></p>
<h2>Oscar Health 股價上漲 0.3%</h2>
<p>OSCR 週一開盤價為 24.59 美元。該股票的市值為 74.1 億美元，市盈率為 -41.68，市盈增長比率為 1.71，貝塔值為 2.37。該公司的速動比率為 1.11，流動比率為 1.11，債務與股本比率為 0.26。該業務的 50 日移動平均線為 18.39 美元，200 日移動平均線為 16.07 美元。Oscar Health, Inc. 的 52 周最低價為 10.69 美元，52 周最高價為 25.58 美元。</p>
<p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近於 5 月 6 日發佈了其財報。該公司報告季度每股收益為 2.07 美元，超出分析師一致預期的 1.11 美元，超出幅度為 0.96 美元。該季度的收入為 46.5 億美元，而分析師預期為 49 億美元。Oscar Health 的股本回報率為 -3.26%，淨利潤率為 -0.30%。該公司的季度收入同比增長 52.6%。去年同期，該公司每股收益為 0.92 美元。股票研究分析師預測，Oscar Health, Inc. 在當前財年將發佈 0.47 美元的每股收益。</p>
<h2>影響 Oscar Health 的關鍵頭條</h2>
<p>以下是本週影響 Oscar Health 的關鍵新聞：</p>
<ul>
<li>積極情緒：富國銀行將 Oscar Health 的評級從 <strong>“強烈賣出” 上調至 “持有”</strong>，儘管其 20 美元的目標價仍低於當前股價，緩解了看空情緒。Zacks.com</li>
<li>積極情緒：Oscar Health 最近的財報顯示 <strong>大幅超出每股收益預期</strong>，儘管收入低於預期，但支持了該股票的基本面故事。</li>
<li>中性情緒：一位公司聯合創始人轉任 <strong>顧問領導角色</strong>，看起來像是內部重組，而不是顛覆性變化。Oscar Health 聯合創始人轉任顧問領導角色</li>
<li>中性情緒：多位內部人士，包括 <strong>首席財務官 Richard Scott Blackley</strong> 和 <strong>首席行政官 Victoria Baltrus</strong>，在預先計劃的 10b5-1 計劃下出售股份，以覆蓋已歸屬股權獎勵的税務義務，這比自願出售的擔憂要小。</li>
<li>消極情緒：董事 <strong>Mario Schlosser</strong> 出售了 <strong>34,120 股</strong>，這是最新一批內部人士出售中最大的一筆，儘管是預先安排的，但可能會對市場情緒造成壓力。</li>
</ul>
<h2>內部人士買賣情況</h2>
<p>在其他新聞中，內部人士亞當·麥克納尼（Adam Mcananey）於 6 月 2 日星期二出售了 9,859 股公司的股票。股票以平均價格 21.94 美元出售，總價值為 216,306.46 美元。交易完成後，該內部人士在公司持有 218,096 股，價值為 4,785,026.24 美元。這筆交易代表其持股減少了 4.32%。該交易在向美國證券交易委員會（SEC）提交的文件中披露，文件可通過此超鏈接獲取。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。此外，首席財務官理查德·斯科特·布萊克利（Richard Scott Blackley）於 5 月 14 日星期四出售了 100,000 股公司的股票。這些股票以平均價格 23.16 美元出售，總價值為 2,316,000.00 美元。交易完成後，首席財務官持有 1,216,660 股公司的股票，價值約為 28,177,845.60 美元。這筆交易代表其持股減少了 7.59%。該銷售的 SEC 文件提供了更多信息。該交易是在預先安排的 10b5-1 交易計劃下執行的。內部人士在過去一個季度共出售了 189,660 股公司股票，價值 4,283,140 美元。公司內部人士持有公司 25.11% 的股票。</p>
<h2>Oscar Health 公司簡介</h2>
<p>（免費報告）</p>
<p>Oscar Health 在紐約證券交易所以 OSCR 的股票代碼交易，是一家以技術驅動的健康保險公司，總部位於紐約。該公司由馬里奧·施洛瑟（Mario Schlosser）、約書亞·庫什納（Joshua Kushner）和凱文·納澤米（Kevin Nazemi）於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
<p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Oscar Health</li>
<li>這三隻保險股票創下 52 周新高：還有買入的機會嗎？</li>
<li>三隻 20 美元以下的股票，值得在更廣泛的市場反彈前買入</li>
<li>Petco 面臨激烈競爭，但勢頭正在增強</li>
<li>鎖定效應是真實存在的——這三家房屋建築商正在押注於此</li>
</ul>
<p><strong>想看看其他對 OSCR 感興趣的對沖基金持有哪些股票？</strong> 請訪問 HoldingsChannel.com，獲取 Oscar Health, Inc.（紐約證券交易所：OSCR - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
<p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場關注之前買入……而 Oscar Health 並不在名單上。</p>
<p>雖然 Oscar Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OSCR

OSCG

OSCX

<p>WINTON GROUP Ltd 在第四季度建立了 210 萬美元的 Oscar Health (OSCR) 頭寸，根據 SEC 文件購買了 146,030 股。機構持股比例為 75.7%。分析師最近調整了價格目標和評級：富國銀行將目標價設定為 20 美元，評級為 “持平”，而瑞士銀行將目標價上調至 20 美元。平均分析師評級為 “持有”，目標價為 20.22 美元。Oscar Health 最近報告了第一季度每股收益為 2.07 美元，超出預期，但收入未達標</p>

<p>WINTON GROUP Ltd purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 146,030 shares of the company's stock, valued at approximately $2,098,000. WINTON GROUP Ltd owned about 0.06% of Oscar Health at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>WINTON GROUP Ltd 在最近向美國證券交易委員會提交的 13F 文件中披露，在第四季度購買了 Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 免費報告）的新股份。該公司購買了 146,030 股，價值約為 2,098,000 美元。WINTON GROUP Ltd 在最近的報告期末持有 Oscar Health 約 0.06% 的股份。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只小盤股具有爆炸性上漲潛力</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also bought and sold shares of OSCR. Jones Financial Companies Lllp grew its position in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio bought a new stake in shares of Oscar Health in the 1st quarter worth approximately $30,000. Fifth Third Bancorp grew its position in shares of Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company's stock worth $34,000 after buying an additional 1,413 shares during the last quarter. Quarry LP grew its position in shares of Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company's stock worth $34,000 after buying an additional 1,469 shares during the last quarter. Finally, Binnacle Investments Inc bought a new stake in shares of Oscar Health in the 2nd quarter worth approximately $75,000. 75.70% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他幾家機構投資者和對沖基金也買賣了 OSCR 的股份。Jones Financial Companies Lllp 在第一季度將其在 Oscar Health 的持倉增加了 7,473.3%。Jones Financial Companies Lllp 現在擁有 2,272 股該公司的股票，價值 30,000 美元，此前在上個季度額外購買了 2,242 股。Strs Ohio 在第一季度購買了價值約 30,000 美元的 Oscar Health 新股份。Fifth Third Bancorp 在第四季度將其在 Oscar Health 的持倉增加了 148.7%。Fifth Third Bancorp 現在擁有 2,363 股該公司的股票，價值 34,000 美元，此前在上個季度額外購買了 1,413 股。Quarry LP 在第三季度將其在 Oscar Health 的持倉增加了 439.8%。Quarry LP 現在擁有 1,803 股該公司的股票，價值 34,000 美元，此前在上個季度額外購買了 1,469 股。最後，Binnacle Investments Inc 在第二季度購買了價值約 75,000 美元的 Oscar Health 新股份。目前，75.70% 的股票由機構投資者持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調與下調</h2>
</div><p>A number of equities research analysts have recently weighed in on the company. Wells Fargo &amp; Company set a $20.00 price objective on Oscar Health and gave the stock an &#34;equal weight&#34; rating in a research report on Thursday. Robert W. Baird lifted their price objective on Oscar Health from $15.00 to $19.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, May 7th. Jefferies Financial Group upgraded Oscar Health from an &#34;underperform&#34; rating to a &#34;hold&#34; rating and lifted their price objective for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. UBS Group lifted their price objective on Oscar Health from $15.00 to $20.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, May 7th. Finally, Barclays lifted their price objective on Oscar Health from $21.00 to $30.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of &#34;Hold&#34; and an average target price of $20.22.</p>
<div class="lb-trans"><p>一些股票研究分析師最近對該公司發表了看法。富國銀行設定了 Oscar Health 的目標價為 20.00 美元，並在週四的研究報告中給予該股票 “持平” 評級。Robert W. Baird 將 Oscar Health 的目標價從 15.00 美元上調至 19.00 美元，並在週四的研究報告中給予該股票 “中性” 評級。Jefferies Financial Group 將 Oscar Health 的評級從 “表現不佳” 上調至 “持有”，並在 4 月 20 日的研究報告中將該股票的目標價從 10.00 美元上調至 16.00 美元。瑞銀集團將 Oscar Health 的目標價從 15.00 美元上調至 20.00 美元，並在週四的研究報告中給予該股票 “中性” 評級。最後，巴克萊將 Oscar Health 的目標價從 21.00 美元上調至 30.00 美元，並在週二的研究報告中給予該股票 “持平” 評級。一位研究分析師給予該股票 “強烈買入” 評級，兩位給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該公司的平均評級為 “持有”，平均目標價為 20.22 美元。</p>
</div><p><strong>Get Our Latest Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 OSCR 的最新報告</strong></p>
</div><h2>Oscar Health Trading Up 0.3%</h2>
<div class="lb-trans"><h2>Oscar Health 股價上漲 0.3%</h2>
</div><p>OSCR opened at $24.59 on Monday. The stock has a market cap of $7.41 billion, a PE ratio of -41.68, a PEG ratio of 1.71 and a beta of 2.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The business has a 50 day moving average of $18.39 and a 200-day moving average of $16.07. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $25.58.</p>
<div class="lb-trans"><p>OSCR 週一開盤價為 24.59 美元。該股票的市值為 74.1 億美元，市盈率為 -41.68，市盈增長比率為 1.71，貝塔值為 2.37。該公司的速動比率為 1.11，流動比率為 1.11，債務與股本比率為 0.26。該業務的 50 日移動平均線為 18.39 美元，200 日移動平均線為 16.07 美元。Oscar Health, Inc. 的 52 周最低價為 10.69 美元，52 周最高價為 25.58 美元。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.96. The company had revenue of $4.65 billion during the quarter, compared to analysts' expectations of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm's revenue for the quarter was up 52.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.92 EPS. Equities research analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近於 5 月 6 日發佈了其財報。該公司報告季度每股收益為 2.07 美元，超出分析師一致預期的 1.11 美元，超出幅度為 0.96 美元。該季度的收入為 46.5 億美元，而分析師預期為 49 億美元。Oscar Health 的股本回報率為 -3.26%，淨利潤率為 -0.30%。該公司的季度收入同比增長 52.6%。去年同期，該公司每股收益為 0.92 美元。股票研究分析師預測，Oscar Health, Inc. 在當前財年將發佈 0.47 美元的每股收益。</p>
</div><h2>Key Headlines Impacting Oscar Health</h2>
<div class="lb-trans"><h2>影響 Oscar Health 的關鍵頭條</h2>
</div><p>Here are the key news stories impacting Oscar Health this week:</p>
<div class="lb-trans"><p>以下是本週影響 Oscar Health 的關鍵新聞：</p>
</div><ul>
<li>Positive Sentiment: Wells Fargo upgraded Oscar Health from <strong>“strong sell” to “hold”</strong>, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com</li>
<li>Positive Sentiment: Oscar Health’s recent earnings showed a <strong>major EPS beat</strong>, which supports the stock’s fundamental story despite revenue coming in below estimates.</li>
<li>Neutral Sentiment: A company co-founder shifting into an <strong>advisory leadership role</strong> looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role</li>
<li>Neutral Sentiment: Multiple insiders, including <strong>CFO Richard Scott Blackley</strong> and <strong>CAO Victoria Baltrus</strong>, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.</li>
<li>Negative Sentiment: Director <strong>Mario Schlosser</strong> sold <strong>34,120 shares</strong>, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：富國銀行將 Oscar Health 的評級從 <strong>“強烈賣出” 上調至 “持有”</strong>，儘管其 20 美元的目標價仍低於當前股價，緩解了看空情緒。Zacks.com</li>
<li>積極情緒：Oscar Health 最近的財報顯示 <strong>大幅超出每股收益預期</strong>，儘管收入低於預期，但支持了該股票的基本面故事。</li>
<li>中性情緒：一位公司聯合創始人轉任 <strong>顧問領導角色</strong>，看起來像是內部重組，而不是顛覆性變化。Oscar Health 聯合創始人轉任顧問領導角色</li>
<li>中性情緒：多位內部人士，包括 <strong>首席財務官 Richard Scott Blackley</strong> 和 <strong>首席行政官 Victoria Baltrus</strong>，在預先計劃的 10b5-1 計劃下出售股份，以覆蓋已歸屬股權獎勵的税務義務，這比自願出售的擔憂要小。</li>
<li>消極情緒：董事 <strong>Mario Schlosser</strong> 出售了 <strong>34,120 股</strong>，這是最新一批內部人士出售中最大的一筆，儘管是預先安排的，但可能會對市場情緒造成壓力。</li>
</ul>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部人士買賣情況</h2>
</div><p>In other news, insider Adam Mcananey sold 9,859 shares of the firm's stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at $4,785,026.24. This trade represents a 4.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Scott Blackley sold 100,000 shares of the firm's stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $23.16, for a total value of $2,316,000.00. Following the completion of the transaction, the chief financial officer owned 1,216,660 shares of the company's stock, valued at approximately $28,177,845.60. The trade was a 7.59% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 189,660 shares of company stock worth $4,283,140 over the last quarter. Company insiders own 25.11% of the company's stock.</p>
<div class="lb-trans"><p>在其他新聞中，內部人士亞當·麥克納尼（Adam Mcananey）於 6 月 2 日星期二出售了 9,859 股公司的股票。股票以平均價格 21.94 美元出售，總價值為 216,306.46 美元。交易完成後，該內部人士在公司持有 218,096 股，價值為 4,785,026.24 美元。這筆交易代表其持股減少了 4.32%。該交易在向美國證券交易委員會（SEC）提交的文件中披露，文件可通過此超鏈接獲取。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。此外，首席財務官理查德·斯科特·布萊克利（Richard Scott Blackley）於 5 月 14 日星期四出售了 100,000 股公司的股票。這些股票以平均價格 23.16 美元出售，總價值為 2,316,000.00 美元。交易完成後，首席財務官持有 1,216,660 股公司的股票，價值約為 28,177,845.60 美元。這筆交易代表其持股減少了 7.59%。該銷售的 SEC 文件提供了更多信息。該交易是在預先安排的 10b5-1 交易計劃下執行的。內部人士在過去一個季度共出售了 189,660 股公司股票，價值 4,283,140 美元。公司內部人士持有公司 25.11% 的股票。</p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health 在紐約證券交易所以 OSCR 的股票代碼交易，是一家以技術驅動的健康保險公司，總部位於紐約。該公司由馬里奧·施洛瑟（Mario Schlosser）、約書亞·庫什納（Joshua Kushner）和凱文·納澤米（Kevin Nazemi）於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?</li>
<li>3 Stocks Under $20 to Buy Before a Broader Market Rally</li>
<li>Petco Faces Tough Competition, But Momentum Is Building</li>
<li>The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Oscar Health</li>
<li>這三隻保險股票創下 52 周新高：還有買入的機會嗎？</li>
<li>三隻 20 美元以下的股票，值得在更廣泛的市場反彈前買入</li>
<li>Petco 面臨激烈競爭，但勢頭正在增強</li>
<li>鎖定效應是真實存在的——這三家房屋建築商正在押注於此</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 OSCR 感興趣的對沖基金持有哪些股票？</strong> 請訪問 HoldingsChannel.com，獲取 Oscar Health, Inc.（紐約證券交易所：OSCR - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場關注之前買入……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Oscar Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

WINTON GROUP Ltd Takes $2.10 Million Position in Oscar Health, Inc. $OSCR

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

五三銀行

富國銀行

Jefferies Financial

瑞銀集團

巴克萊銀行

五三銀行-存託優先股Series K

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

五三銀行-Series A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

WINTON GROUP Ltd 在 Oscar Health, Inc. $OSCR 中建立了 210 萬美元的頭寸